Clinical Trials Logo
  1. Home
  2. Iron Deficiency Anemia
  3. NCT02541708

IV Ferric Carboxymaltose Compared With Oral Iron in the Treatment of Iron Deficiency Anemia at Delivery in Tanzania — Ferinject  

Iron-Deficiency Anemia Clinical Trial

Official title:
Intravenous Ferric Carboxymaltose Compared With Oral Iron in the Treatment of Iron Deficiency Anemia at Delivery in Tanzania

Clinical Trial Summary

Intravenous iron preparations have been shown to be superior to oral iron and have largely replaced the treatment of anaemia in Northern countries. However, the socio-economic and medical conditions in low resource countries greatly differ from those in northern countries. Patients' different access to medication supply, perception of medication need and compliance as well as the burden of concomitant disease like malaria, soil-transmitted helminths, schistosomiasis, HIV and red blood cells (RBC) genetic disorders may influence effectiveness and safety of iron substitution modality. The aim of the present study is to compare iv iron substitution by ferric carboxymaltose (Ferinject®) to per oral iron substitution in a low resource country

Clinical Trial Description

The objectives of the study are as follows:

Primary objective:

To assess the superiority in terms of effectiveness of iv iron substitution with ferric carboxymaltose versus per oral iron substitution in women with iron deficient anemia at delivery in Tanzania.

Secondary objectives

- To evaluate safety and feasibility of intravenous ferric carboxymaltose substitution compared to per oral iron substitution in a resource limited country

- To evaluate acceptance of intravenous ferric carboxymaltose substitution compared to per oral iron substitution in a resource limited country

- To evaluate wellbeing of women receiving intravenous ferric carboxymaltose compared to women receiving per oral iron substitution

- To evaluate the sensitivity of diagnosis of iron deficiency by measuring hemoglobin, mean corpuscular volume (MCV) and mean corpuscular hemoglobin concentration (MCHC) only, compared to the diagnosis by measuring iron metabolism parameters in a resource limited country ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02541708
Study type Interventional
Source Ifakara Health Institute
Contact
Status Active, not recruiting
Phase Phase 3
Start date September 2015
Completion date April 2018
View Details
See also
  Status Clinical Trial Phase
Completed NCT04949165 - Bloodsafe Ghana- Iron and Nutritional Counseling Strategy Pilot Study N/A
Completed NCT01942460 - Ferumoxytol for Iron-Deficiency Anemia in Chronic Kidney Disease and Peritoneal Dialysis Patients Phase 4
Completed NCT00810030 - FERINJECT for Correction of Anaemia in IBD Patients, FER-IBD-COR Phase 3
Completed NCT01047098 - Effects of Taking Prenatal Vitamin-mineral Supplements During Lactation on Iron Status and Markers of Oxidation N/A
Completed NCT00298051 - Umbilical Cord Clamping and Infant Iron Status N/A
Completed NCT01135576 - Iron Fortified Beverages and Application in Women Predisposed to Anemia N/A
Withdrawn NCT04320966 - Neurovascular Complications and White Matter Damage in Acquired Anemias
Completed NCT01101399 - Ferric Carboxymaltose in Subjects With Functional Iron Deficiency Undergoing Chemotherapy Phase 3
Completed NCT05240677 - Endoscopy in CKD With Iron Deficiency Anemia N/A
Terminated NCT01100879 - Ferric Carboxymaltose for Treatment of Anaemia of Cancer in Subjects With Multiple Myeloma Receiving Chemotherapy Phase 4
Recruiting NCT02487719 - Different Iron Supplements for Prevention of Anemia in Pregnancy Phase 4
Recruiting NCT03232554 - Buxue Yimu Pills for Gynecological Iron-Deficiency Anemia Phase 2
Terminated NCT02341300 - Use of Cast Iron Pots to Improve Maternal Anemia N/A
Completed NCT04318405 - Real Life Study on Iron Isomaltoside 1000 in the Treatment of ID in CKD, Heart Failure, ObGyn, IBD, Cancer and Elective Surgery (Real-CHOICE).
Completed NCT02998697 - Short Term Oral Iron Supplementation in Systolic Heart Failure Patients Suffering From Iron Deficiency Anemia Phase 2/Phase 3
Not yet recruiting NCT03411590 - The Effect of Fortified Growing-up Milk on Growth and Micronutrient Status of Nigerian Toddlers N/A
Completed NCT05365308 - EHR-based Patient Identification and Panel Management of Patients With Iron Deficiency Anemia N/A
Recruiting NCT01071759 - Effects of Dietary Heme/Non-heme Iron and Helicobacter Pylori (Hp) Infection on Maternal Iron-deficiency Anemia and Fetal Growth Outcomes N/A
Terminated NCT00882414 - Ferinject® in Patient With Thrombocytosis Secondary to Inflammatory Bowel Disease (IBD) Phase 2
Completed NCT02968368 - Study With Oral Ferric Maltol for the Treatment of Iron Deficiency Anemia in Subjects With Chronic Kidney Disease Phase 3